Global Influenza Diagnostics
Market Report
2025
Influenza Diagnostics Market Report 2025 (Global Edition)
As per Cognitive Market Research's latest published report, the Global Influenza Diagnostics market size was $843.8 Million in 2022 and it is forecasted to reach $1,425.2 Million by 2030. Influenza Diagnostics Industry's Compound Annual Growth Rate will be 7.83% from 2023 to 2030.
The base year for the calculation is 2023 and 2019 to 2023 will be historical period. The year 2024 will be estimated one while the forecasted data will be from year 2025 to 2031. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
| Share your contact details to receive free updated sample copy/pages of the recently published edition of Influenza Diagnostics Market Report 2024.
Global Influenza Diagnostics Market Report 2024 Market Size Split by Product (Test Kits, Reagents, Instruments), by Test Type (RIDT, RT-PCR, Cell Culture), by End-use (Hospitals, Laboratories, POCT)
As per Cognitive Market Research's latest published report, the Global Influenza Diagnostics market size was $843.8 Million in 2022 and it is forecasted to reach $1,425.2 Million by 2030. Influenza Diagnostics Industry's Compound Annual Growth Rate will be 7.83% from 2023 to 2030.
| Base Year | 2023 |
| Historical Data Time Period | 2019-2023 |
| Forecast Period | 2024-2031 |
| Global Influenza Diagnostics Market Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 7.83% |
| Market Split by Product |
|
| Market Split by Test Type |
|
| Market Split by End-use |
|
| List of Competitors |
|
| Regional Analysis |
|
Country Analysis |
|
Report scope is customizable as we have a huge database of Influenza Diagnostics industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Influenza Diagnostics Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Influenza Diagnostics Market Report Description
Introduction of Influenza Diagnostics
Influenza is a type of viral infection that causes serious morbidity and mortality all over the world. Influenzas are of three types: Type A, Type B, and Type C. Influenza A is the most responsible for pandemics. Tests for diagnosis of influenza viruses in the respiratory system are molecular assays, RT-PCR tests, RIDT, and antigen detection tests. Influenza is a very contagious disease coupled with symptoms like fever, cough, myalgias, chills or sweats, etc. Rising demand for rapid diagnostic tests, increasing prevalence of influenza, and technological advancements are fueling the growth of the influenza diagnostic market.
Influenza Diagnostics Market Size
What is driving the Influenza Diagnostics Market?
-
Rising prevalence of influenza A will boost the Influenza Diagnostics market
Influenza A is the most common and highly contagious respiratory illness which can cause morbidity and mortality. The rising prevalence of influenza A will boost the influenza diagnostic market at a lucrative rate. The Centers for Disease Control and Prevention (CDC) forecasted that influenza causes around 12000 to 79000 fatalities annually in the US. The influenza diagnostic market is predicted to develop in the foreseeable future owing to the rising awareness about the early diagnosis and prevention of influenza.
-
Growing research in influenza diagnostic technologies will fuel the Influenza Diagnostics market
An increase in R&D activities for effective diagnosis of influenza is fueling the market toward developing faster and more accurate diagnostic solutions which will aid the growth of the influenza diagnostic market. Rising government initiatives, a growing geriatric population, and advancements in diagnostic technology will expand the market in the forecasted period.
Restraining Factor for Influenza Diagnostics Market:
-
Cost of tests and lack of skilled personnel will hamper the market growth
The cost associated with diagnostic tests is anticipated to hamper the market growth. Raw material accessibility and availability limitations resulted in an increase in the cost of diagnostic kits and products. High manufacturing expenses are passed on to end customers in the form of high prices, thus impeding the influenza diagnostic market.
Lack of skilled personnel, healthcare infrastructure, and unstable regulatory framework of diagnostic test approval will retard the growth of the influenza diagnostic market.
Impact of the COVID-19 Pandemic on the Influenza Diagnostics Market:
The outbreak of COVID-19 had a notable impact on the influenza diagnostics market owing to shut down of manufacturing plants due to restrictions like lockdown and social distancing, unfavorable regulations, and disruption in supply chain management. COVID-19 and influenza have several similarities such as contagiousness and respiratory illness. Thus, it was necessary to diagnose influenza early for safety purposes which increased the market for influenza diagnostic tests.
We have various report editions of Influenza Diagnostics Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Influenza Diagnostics Market Insights Video
Competitive Analysis of the Influenza Diagnostics Market:
The influenza diagnostic market is highly competitive and consolidated in nature due to the dominance of a few major players. The majority of players are focusing on adopting strategies such as new product launches, vertical collaboration, technological developments and discoveries, mergers and acquisitions, etc.
Influenza Diagnostics Market News
- February 2023 - Becton, Dickinson, and Company received FDA Emergency Use Authorization for Influenza A/B, COVID-19, RSV Combination Test:
BD, a leading company, received Emergency Use Authorization from US FDA for a new molecular diagnostic combination test. The test uses a single nasal swab to identify influenza and other combinations of viruses within two hours.
- July 2022 - Thermo Fisher Scientific launched CE-IVD marked TaqPath respiratory viral select panel:
Thermo Fisher Scientific, the world's leading company in serving science announced the launch of the applied biosystem TaqPath respiratory vira; select panel. The molecular assay panel detects five common viruses causing the common cold, croup, bronchiolitis, influenza, and pneumonia. The panel provides results in three hours using accurate PCR technology.
- June 2022 - Seegene got approval from the EU for Allplex respiratory panel assay:
Seegene IncSouth Korea’s leading molecular diagnostics company has obtained EU approval for Alllplex respiratory panel assay for SARS-Co-2, influenza A and B, etc which can assist small hospitals, and clinics for effective identification.
Top Companies Market Share in Influenza Diagnostics Industry: (In no particular order of Rank)
- 3M
- Thermo Fisher Scientific Inc.
- Abbott Laboratories Inc.
- Meridian Bioscience Inc.
- Becton
- Dickinson
- and Company (Bd)
- F. Hoffmann-LA Roche AG
- Quidel Corporation
- DiaSorin Molecular
- SA Scientific
- Sekisui Diagnostics
- Hologic Inc.
- Confidential Data
- Access The Paid Version
- Data Hidden
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
The North America Influenza Diagnostics market accounts for the major revenue share!
The North America region holds the major revenue share of the market and it is predicted to continue its dominance in the upcoming period. The dominance can be attributed to the rising government surveillance, the presence of major key players in the region, and the growth in research for influenza diagnostic technologies.
The current report Scope analyzes Influenza Diagnostics Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
- North America (United States, Canada, Mexico)
- Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
- Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
- South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
- Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)
Influenza Diagnostics Market Share (%) by Region (2019-2031)
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
Influenza Diagnostics Market Analysis
Global Influenza Diagnostics Market Report 2024 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Influenza Diagnostics Industry growth. Influenza Diagnostics market has been segmented with the help of its Product, Test Type End-use, and others. Influenza Diagnostics market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
By Product, the Test kits segment is the dominating segment of the Influenza Diagnostics market!
Based on product, the market is segmented into test kits, reagents, and instruments. The test kits segment is the dominating segment of the market owing to the rising prevalence of influenza and the surge in demand for rapid diagnostic tests. The test kits are mostly used in hospitals and diagnostic centers for rapid and accurate diagnosis of influenza.
- Test Kits
- Reagents
- Instruments
Influenza Diagnostics Market Share (%) by Product in 2019-2031
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Influenza Diagnostics Industry. Request a Free Sample PDF!
By Test type, the RIDT (rapid influenza diagnostic tests) segment holds the largest share of the Influenza Diagnostics market!
On the basis of Test Type, The RIDT (rapid influenza diagnostic tests) holds the largest share of the market and it is predicted to grow with the highest CAGR in upcoming years. The dominance of this segment is due to increasing test surveillance, numerous RIDT approvals, and rising patient management for influenza diagnosis coupled with increasing monitoring of flu in public events is anticipated to boost the influenza diagnostic market.
- RIDT
- RT-PCR
- Cell Culture
Influenza Diagnostics Market Share (%) by Test Type in 2019-2031
2019
2023
2031
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
Influenza Diagnostics End-use Segment Analysis
By End-use, the Hospital segment is the major segment of Influenza Diagnostics Market!
On the basis of end-use, the market is segmented into hospitals, laboratories, and POCT. The hospital segment is the major segment contributing to the revenue share of the market. Owing to a large number of hospitalisation cases due to seasonal influenza the hospital segment is growing.
- Hospitals
- Laboratories
- POCT
Author's Detail
Manjiri KanhereSenior Research Associate at Cognitive Market Research
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over three years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies.
In her current role, Manjiri handles the market research related to Pharma and healthcare industry. Her passion lies in utilizing innovative approaches to distill complex information into strategic insights that empower organizations to make informed decisions.Manjiri remains an invaluable asset in the dynamic landscape of market research.
Author's Conclusion
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Influenza Diagnostics Market is witnessing significant growth in the near future.
In 2023, the Test Kits segment accounted for noticeable share of global Influenza Diagnostics Market and is projected to experience significant growth in the near future.
The RIDT segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies 3M , Abbott Laboratories Inc. and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.
Frequently Asked Questions (FAQs)
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Latest News about Influenza Diagnostics Market
Sources from Pharma & Healthcare Industry
- https://en.wikipedia.org/wiki/American_Society_for_Pharmacy_Law
- https://en.wikipedia.org/wiki/American_Society_of_Consultant_Pharmacists
- https://en.wikipedia.org/wiki/American_Society_of_Health-System_Pharmacists
- https://www.apsm-uk.com/
- https://en.wikipedia.org/wiki/Australasian_College_of_Pharmacy
- https://en.wikipedia.org/wiki/American_Association_of_Colleges_of_Pharmacy
- https://en.wikipedia.org/wiki/American_College_of_Clinical_Pharmacy
- https://en.wikipedia.org/wiki/American_Pharmacists_Association
- https://www.bio.org/
- https://en.wikipedia.org/wiki/Canadian_Pharmacists_Association
- https://en.wikipedia.org/wiki/Canadian_Society_of_Hospital_Pharmacists
- https://en.wikipedia.org/wiki/Chinese_Pharmaceutical_Association
- https://en.wikipedia.org/wiki/American_Association_of_Psychiatric_Pharmacists
- https://en.wikipedia.org/wiki/Danish_Association_of_Pharmaconomists
- https://en.wikipedia.org/wiki/EPhEU
- https://www.fda.gov/
- https://www.gmc-uk.org/
- https://www.ifpma.org/
- https://www.fip.org/
- https://en.wikipedia.org/wiki/International_Pharmaceutical_Students%27_Federation
- https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency
- https://en.wikipedia.org/wiki/National_Pharmacy_Association
- https://en.wikipedia.org/wiki/Norwegian_Pharmacy_Association
- https://en.wikipedia.org/wiki/Canadian_Pharmacists_Journal#History
- https://en.wikipedia.org/wiki/Pakistan_Pharmacists_Association
- https://en.wikipedia.org/wiki/Pharmaceutical_Association_of_Mauritius
- https://en.wikipedia.org/wiki/Pharmaceutical_Group_of_the_European_Union
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_Australia
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_New_Zealand
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_Northern_Ireland
- https://en.wikipedia.org/wiki/Professional_Compounding_Centers_of_America
- https://en.wikipedia.org/wiki/Royal_Pharmaceutical_Society
- https://www.aaps.org/home
- https://www.bioindustry.org/
- https://www.controlledreleasesociety.org/
- https://www.efpia.eu/
- https://www.epemed.org/online/www/content/ENG/index.html
- https://icr-global.org/
- https://ispe.org/
- https://en.wikipedia.org/wiki/Pharmaceutical_Association_of_Israel
- https://www.phrma.org/
- https://en.wikipedia.org/wiki/The_Pharmacy_Guild_of_Australia
- https://en.wikipedia.org/wiki/The_Society_of_Hospital_Pharmacists_of_Australia
- https://en.wikipedia.org/wiki/Healthcare_industry
- https://www.pharma-iq.com/business-development/articles/top-50-pharmaceutical-blogs-and-publications
- https://www.pharmatimes.com/news
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967517/
- https://www.cbo.gov/publication/57126
- http://: https://www.who.int/tools/atc-ddd-toolkit/data
- https://www.oecd.org/els/health-systems/health-data.htm
- https://www.bls.gov/ooh/healthcare/home.htm
- https://data.worldbank.org/topic/8
- https://www.statnews.com/about/
- https://www.health.pa.gov/topics/HealthStatistics/Pages/health-statistics.aspx
- https://www.cdc.gov/nchs/index.htm
- https://www.aha.org/statistics/fast-facts-us-hospitals
- https://www.census.gov/library/publications/2021/demo/p60-274.html
- https://www.adb.org/what-we-do/sectors/health/main
Influenza Diagnostics Market Report Table of Content
Disclaimer:
- This is just a redacted sample pages of the actual deliverable report and only for representative purposes
- Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
- The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
- Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
- If applicable; On Request Volume Data will also be provided (at an Additional Cost).
| Product | Test Kits, Reagents, Instruments |
| Test Type | RIDT, RT-PCR, Cell Culture |
| End-use | Hospitals, Laboratories, POCT |
| List of Competitors | 3M, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Meridian Bioscience Inc., Becton, Dickinson, and Company (Bd), F. Hoffmann-LA Roche AG, Quidel Corporation, DiaSorin Molecular, SA Scientific, Sekisui Diagnostics, Hologic Inc. |
This chapter will help you gain GLOBAL Market Analysis of Influenza Diagnostics. Further deep in this chapter, you will be able to review Global Influenza Diagnostics Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
-
1.1 Global Influenza Diagnostics Revenue Market Size, Trend Analysis 2019 - 2031
-
1.2 Global Influenza Diagnostics Market Size By Regions 2019 - 2031
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
-
1.2.1 Global Influenza Diagnostics Revenue Market Size By Region
-
-
1.3 Global Influenza Diagnostics Market Size By Product 2019 -2031
-
1.3.1 Test Kits Market Size
-
1.3.2 Reagents Market Size
-
1.3.3 Instruments Market Size
-
-
1.4 Global Influenza Diagnostics Market Size By Test Type 2019 -2031
-
1.4.1 RIDT Market Size
-
1.4.2 RT-PCR Market Size
-
1.4.3 Cell Culture Market Size
-
-
1.5 Global Influenza Diagnostics Market Size By End-use 2019 -2031
-
1.5.1 Hospitals Market Size
-
1.5.2 Laboratories Market Size
-
1.5.3 POCT Market Size
-
-
1.6 Global Level Competitor Analysis (Subject to Data Availability (Private Players))
-
1.7 Executive Summary Global Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
-
1.7.1 Regional Market Revenue Summary 2019 vs 2024 vs 2031
-
1.7.2 Global Market Revenue Split By Product
-
1.7.3 Global Market Revenue Split By Test Type
-
1.7.4 Global Market Revenue Split By End-use
-
1.7.5 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
-
This chapter will help you gain North America Market Analysis of Influenza Diagnostics. Further deep in this chapter, you will be able to review North America Influenza Diagnostics Market Split by various segments and Country Split.
Chapter 2 North America Market Analysis
-
2.1 North America Influenza Diagnostics Market Size 2019 - 2031
-
2.1.1 North America Influenza Diagnostics Market Size By Country 2019 - 2031
-
2.1.2 North America Influenza Diagnostics Market Size by Product 2019 -2031
-
2.1.2.1 North America Test Kits Market Size
-
2.1.2.2 North America Reagents Market Size
-
2.1.2.3 North America Instruments Market Size
-
-
2.1.3 North America Influenza Diagnostics Market Size by Test Type 2019 -2031
-
2.1.3.1 North America RIDT Market Size
-
2.1.3.2 North America RT-PCR Market Size
-
2.1.3.3 North America Cell Culture Market Size
-
-
2.1.4 North America Influenza Diagnostics Market Size by End-use 2019 -2031
-
2.1.4.1 North America Hospitals Market Size
-
2.1.4.2 North America Laboratories Market Size
-
2.1.4.3 North America POCT Market Size
-
-
This chapter will help you gain Europe Market Analysis of Influenza Diagnostics. Further deep in this chapter, you will be able to review Europe Influenza Diagnostics Market Split by various segments and Country Split.
Chapter 3 Europe Market Analysis
-
3.1 Europe Influenza Diagnostics Market Size 2019 - 2031
-
3.1.1 Europe Influenza Diagnostics Market Size By Country 2019 - 2031
-
3.1.2 Europe Influenza Diagnostics Market Size by Product 2019 -2031
-
3.1.2.1 Europe Test Kits Market Size
-
3.1.2.2 Europe Reagents Market Size
-
3.1.2.3 Europe Instruments Market Size
-
-
3.1.3 Europe Influenza Diagnostics Market Size by Test Type 2019 -2031
-
3.1.3.1 Europe RIDT Market Size
-
3.1.3.2 Europe RT-PCR Market Size
-
3.1.3.3 Europe Cell Culture Market Size
-
-
3.1.4 Europe Influenza Diagnostics Market Size by End-use 2019 -2031
-
3.1.4.1 Europe Hospitals Market Size
-
3.1.4.2 Europe Laboratories Market Size
-
3.1.4.3 Europe POCT Market Size
-
-
This chapter will help you gain Asia Pacific Market Analysis of Influenza Diagnostics. Further deep in this chapter, you will be able to review Asia Pacific Influenza Diagnostics Market Split by various segments and Country Split.
Chapter 4 Asia Pacific Market Analysis
-
4.1 Asia Pacific Influenza Diagnostics Market Size 2019 - 2031
-
4.1.1 Asia Pacific Influenza Diagnostics Market Size By Country 2019 - 2031
-
4.1.2 Asia Pacific Influenza Diagnostics Market Size by Product 2019 -2031
-
4.1.2.1 Asia Pacific Test Kits Market Size
-
4.1.2.2 Asia Pacific Reagents Market Size
-
4.1.2.3 Asia Pacific Instruments Market Size
-
-
4.1.3 Asia Pacific Influenza Diagnostics Market Size by Test Type 2019 -2031
-
4.1.3.1 Asia Pacific RIDT Market Size
-
4.1.3.2 Asia Pacific RT-PCR Market Size
-
4.1.3.3 Asia Pacific Cell Culture Market Size
-
-
4.1.4 Asia Pacific Influenza Diagnostics Market Size by End-use 2019 -2031
-
4.1.4.1 Asia Pacific Hospitals Market Size
-
4.1.4.2 Asia Pacific Laboratories Market Size
-
4.1.4.3 Asia Pacific POCT Market Size
-
-
This chapter will help you gain South America Market Analysis of Influenza Diagnostics. Further deep in this chapter, you will be able to review South America Influenza Diagnostics Market Split by various segments and Country Split.
Chapter 5 South America Market Analysis
-
5.1 South America Influenza Diagnostics Market Size 2019 - 2031
-
5.1.1 South America Influenza Diagnostics Market Size By Country 2019 - 2031
-
5.1.2 South America Influenza Diagnostics Market Size by Product 2019 -2031
-
5.1.2.1 South America Test Kits Market Size
-
5.1.2.2 South America Reagents Market Size
-
5.1.2.3 South America Instruments Market Size
-
-
5.1.3 South America Influenza Diagnostics Market Size by Test Type 2019 -2031
-
5.1.3.1 South America RIDT Market Size
-
5.1.3.2 South America RT-PCR Market Size
-
5.1.3.3 South America Cell Culture Market Size
-
-
5.1.4 South America Influenza Diagnostics Market Size by End-use 2019 -2031
-
5.1.4.1 South America Hospitals Market Size
-
5.1.4.2 South America Laboratories Market Size
-
5.1.4.3 South America POCT Market Size
-
-
This chapter will help you gain Middle East and Africa Market Analysis of Influenza Diagnostics. Further deep in this chapter, you will be able to review Middle East and Africa Influenza Diagnostics Market Split by various segments and Country Split.
Chapter 6 Middle East and Africa Market Analysis
-
6.1 Middle East and Africa Influenza Diagnostics Market Size 2019 - 2031
-
6.1.1 Middle East and Africa Influenza Diagnostics Market Size By Country 2019 - 2031
-
6.1.2 Middle East and Africa Influenza Diagnostics Market Size by Product 2019 -2031
-
6.1.2.1 Middle East and Africa Test Kits Market Size
-
6.1.2.2 Middle East and Africa Reagents Market Size
-
6.1.2.3 Middle East and Africa Instruments Market Size
-
-
6.1.3 Middle East and Africa Influenza Diagnostics Market Size by Test Type 2019 -2031
-
6.1.3.1 Middle East and Africa RIDT Market Size
-
6.1.3.2 Middle East and Africa RT-PCR Market Size
-
6.1.3.3 Middle East and Africa Cell Culture Market Size
-
-
6.1.4 Middle East and Africa Influenza Diagnostics Market Size by End-use 2019 -2031
-
6.1.4.1 Middle East and Africa Hospitals Market Size
-
6.1.4.2 Middle East and Africa Laboratories Market Size
-
6.1.4.3 Middle East and Africa POCT Market Size
-
-
Only Available with Corporate User License
Chapter 7 Top 10 Countries Analysis (Only Available with Corporate User License)
-
7.1 Country 1 Market Analysis
-
7.1.1 Country 1Influenza Diagnostics Market Size by Product 2019 -2031
-
7.1.2 Country 1Influenza Diagnostics Market Size by Test Type 2019 -2031
-
7.1.3 Country 1Influenza Diagnostics Market Size by End-use 2019 -2031
-
-
7.2 Country 2 Market Analysis
-
7.2.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.3 Country 3 Market Analysis
-
7.3.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.4 Country 4 Market Analysis
-
7.4.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.5 Country 5 Market Analysis
-
7.5.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.6 Country 6 Market Analysis
-
7.6.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.7 Country 7 Market Analysis
-
7.7.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.8 Country 8 Market Analysis
-
7.8.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.9 Country 9 Market Analysis
-
7.9.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.10 Country 10 Market Analysis
-
7.10.1 Segmentation Analysis will be provided as shown for Country 1
-
This chapter provides an in-depth analysis of the market share among key competitors of Influenza Diagnostics. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
-
8.1 Top Competitors Analysis
-
8.1.1 Top Players Ranking 2022
-
8.1.2 Global Influenza Diagnostics Market Revenue and Share by Key Players
(Subject to Data Availability (Private Players))
-
8.1.3 Industry Mergers and Acquisition Analysis
-
8.1.4 New Product Launch Analysis
-
-
8.2 Company Profile (Data Subject to Availability)
-
8.2.1 3M
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.1.2 Business Overview
-
8.2.1.3 Financials (Subject to data availability)
-
8.2.1.4 Product Types Specification
-
8.2.1.5 Business Strategy
-
8.2.1.6 S.W.O.TAnalysis
-
-
8.2.2 Thermo Fisher Scientific Inc.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.2.2 Business Overview
-
8.2.2.3 Financials (Subject to data availability)
-
8.2.2.4 Product Types Specification
-
8.2.2.5 Business Strategy
-
8.2.2.6 S.W.O.TAnalysis
-
-
8.2.3 Abbott Laboratories Inc.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.3.2 Business Overview
-
8.2.3.3 Financials (Subject to data availability)
-
8.2.3.4 Product Types Specification
-
8.2.3.5 Business Strategy
-
8.2.3.6 S.W.O.TAnalysis
-
-
8.2.4 Meridian Bioscience Inc.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.4.2 Business Overview
-
8.2.4.3 Financials (Subject to data availability)
-
8.2.4.4 Product Types Specification
-
8.2.4.5 Business Strategy
-
8.2.4.6 S.W.O.TAnalysis
-
-
8.2.5 Becton
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.5.2 Business Overview
-
8.2.5.3 Financials (Subject to data availability)
-
8.2.5.4 Product Types Specification
-
8.2.5.5 Business Strategy
-
8.2.5.6 S.W.O.TAnalysis
-
-
8.2.6 Dickinson
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.6.2 Business Overview
-
8.2.6.3 Financials (Subject to data availability)
-
8.2.6.4 Product Types Specification
-
8.2.6.5 Business Strategy
-
8.2.6.6 S.W.O.TAnalysis
-
-
8.2.7 and Company (Bd)
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.7.2 Business Overview
-
8.2.7.3 Financials (Subject to data availability)
-
8.2.7.4 Product Types Specification
-
8.2.7.5 Business Strategy
-
8.2.7.6 S.W.O.TAnalysis
-
-
8.2.8 F. Hoffmann-LA Roche AG
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.8.2 Business Overview
-
8.2.8.3 Financials (Subject to data availability)
-
8.2.8.4 Product Types Specification
-
8.2.8.5 Business Strategy
-
8.2.8.6 S.W.O.TAnalysis
-
-
8.2.9 Quidel Corporation
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.9.2 Business Overview
-
8.2.9.3 Financials (Subject to data availability)
-
8.2.9.4 Product Types Specification
-
8.2.9.5 Business Strategy
-
8.2.9.6 S.W.O.TAnalysis
-
-
8.2.10 DiaSorin Molecular
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.10.2 Business Overview
-
8.2.10.3 Financials (Subject to data availability)
-
8.2.10.4 Product Types Specification
-
8.2.10.5 Business Strategy
-
8.2.10.6 S.W.O.TAnalysis
-
-
8.2.11 SA Scientific
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.11.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.11.2 Business Overview
-
8.2.11.3 Financials (Subject to data availability)
-
8.2.11.4 Product Types Specification
-
8.2.11.5 Business Strategy
-
8.2.11.6 S.W.O.TAnalysis
-
-
8.2.12 Sekisui Diagnostics
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.12.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.12.2 Business Overview
-
8.2.12.3 Financials (Subject to data availability)
-
8.2.12.4 Product Types Specification
-
8.2.12.5 Business Strategy
-
8.2.12.6 S.W.O.TAnalysis
-
-
8.2.13 Hologic Inc.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.13.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.13.2 Business Overview
-
8.2.13.3 Financials (Subject to data availability)
-
8.2.13.4 Product Types Specification
-
8.2.13.5 Business Strategy
-
8.2.13.6 S.W.O.TAnalysis
-
-
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 9 Qualitative Analysis (Subject to Data Availability)
-
9.1 Market Drivers
-
9.2 Market Restraints
-
9.3 Market Trends
-
9.4 Market Opportunity
-
9.5 Technological Road Map (Subject to Data Availability)
-
9.6 Product Life Cycle (Subject to Data Availability)
-
9.7 Consumer Preference Analysis
-
9.8 Market Attractiveness Analysis
-
9.9 PESTEL Analysis
-
9.9.1 Political Factors
-
9.9.2 Economic Factors
-
9.9.3 Social Factors
-
9.9.4 Technological Factors
-
9.9.5 Legal Factors
-
9.9.6 Environmental Factors
-
-
9.10 Industrial Chain Analysis (Subject to Data Availability)
-
9.10.1 Industry Chain Analysis
-
9.10.2 Manufacturing Cost Analysis
-
9.10.3 Supply Side Analysis
-
9.10.3.1 Raw Material Analysis
-
9.10.3.2 Raw Material Procurement Analysis
-
9.10.3.3 Raw Material Price Trend Analysis
-
-
-
9.11 Porter’s Five Forces Analysis
-
9.11.1 Bargaining Power of Suppliers
-
9.11.2 Bargaining Power of Buyers
-
9.11.3 Threat of New Entrants
-
9.11.4 Threat of Substitutes
-
9.11.5 Degree of Competition
-
-
9.12 Patent Analysis (Subject to Data Availability)
-
9.13 ESG Analysis
Segmentation Product Analysis 2019 -2031, will provide market size split by Product. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Product Analysis 2019 -2031
-
10.1 Test Kits
-
10.1.1 Global Influenza Diagnostics Revenue Market Size and Share by Test Kits 2019 -2031
-
-
10.2 Reagents
-
10.2.1 Global Influenza Diagnostics Revenue Market Size and Share by Reagents 2019 -2031
-
-
10.3 Instruments
-
10.3.1 Global Influenza Diagnostics Revenue Market Size and Share by Instruments 2019 -2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by Test Type Analysis 2019 -2031
-
11.1 RIDT
-
11.1.1 Global Influenza Diagnostics Revenue Market Size and Share by RIDT 2019 - 2031
-
-
11.2 RT-PCR
-
11.2.1 Global Influenza Diagnostics Revenue Market Size and Share by RT-PCR 2019 - 2031
-
-
11.3 Cell Culture
-
11.3.1 Global Influenza Diagnostics Revenue Market Size and Share by Cell Culture 2019 - 2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by End-use Analysis 2019 -2031
-
12.1 Hospitals
-
12.1.1 Global Influenza Diagnostics Revenue Market Size and Share by Hospitals 2019 -2031
-
-
12.2 Laboratories
-
12.2.1 Global Influenza Diagnostics Revenue Market Size and Share by Laboratories 2019 -2031
-
-
12.3 POCT
-
12.3.1 Global Influenza Diagnostics Revenue Market Size and Share by POCT 2019 -2031
-
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Influenza Diagnostics market
Chapter 13 Research Findings
-
13.1 Key Takeaways
-
13.2 Analyst Point of View
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
-
13.3 Assumptions and Acronyms
Sample Format of Deliverables
The Tables, Graphs/Charts are only for representative purposes and do not depict actual statistics. Purchase full Report access to actual data.
Qualitative Analysis
Research Methodology Implemented by Manjiri Kanhere and Team
- 1.1 Influenza Diagnostics Market Report 2024 Research Methodology
- 1.2 Systematic Research Approach
- 1.2.1 Primary Research for Influenza Diagnostics Market
- 1.2.1.1 Key Data from Primary
- 1.2.1.2 Primary Interviews with Experts
- 1.2.1.3 Key Industry Insights
- 1.2.1.4 Questionnaire for Influenza Diagnostics Market
- 1.2.1.5 Breakdown of Primaries
- 1.2.2 Secondary Research for Influenza Diagnostics Market
- 1.2.2.1 Key Data from Secondary
- 1.2.2.2 Paid Sources
- 1.2.2.3 Public Sources
- 1.3 Market Size Estimation for Influenza Diagnostics Market
- 1.3.1 Top-Down Approach
- 1.3.1.1 Analyzing Market Size by Top-Down Approach (Supply Side)
- 1.3.2 Bottom-UP Approach
- 1.3.2.1 Analyzing Market Size by Bottom-Up Approach (Demand Side)
- 1.3.1 Top-Down Approach
- 1.4 Market Breakdown and Data Triangulation
- 1.5 Research Assumptions for Influenza Diagnostics Market
Key Questions Answered By Influenza Diagnostics Market Report 2024
| Why Test Kits have a significant impact on Influenza Diagnostics market? |
| What are the key factors affecting the Test Kits and Reagents of Influenza Diagnostics Market? |
| What is the CAGR/Growth Rate of RIDT during the forecast period? |
| By type, which segment accounted for largest share of the global Influenza Diagnostics Market? |
| Which region is expected to dominate the global Influenza Diagnostics Market within the forecast period? |
| Segmentation Level Customization |
|
| Global level Data Customization |
|
| Region level Data Customization |
|
| Country level Data Customization |
|
| Company Level |
|
| Additional Data Analysis |
|
| Additional Qualitative Data |
|
| Additional Quantitative Data |
|
| Service Level Customization |
|
Report Format Alteration |
|
